BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Aiming at the improvement of diagnostic sensitivity in CML monitoring, we set out to comparatively investigate the impact of two different RTs (MLV RT vs. SuperScript IV RT) and the type of priming (random vs. specific priming) on BCR::ABL1 assay performance.